- Home
- AIRG vs RLMD Comparison
AIRG vs RLMD Comparison
Compare AIRG & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRG
- RLMD
- Stock Information
- Founded
- AIRG 1995
- RLMD 2004
- Country
- AIRG United States
- RLMD United States
- Employees
- AIRG N/A
- RLMD N/A
- Industry
- AIRG Radio And Television Broadcasting And Communications Equipment
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- AIRG Technology
- RLMD Health Care
- Exchange
- AIRG Nasdaq
- RLMD Nasdaq
- Market Cap
- AIRG 108.4M
- RLMD 110.6M
- IPO Year
- AIRG 2016
- RLMD N/A
- Fundamental
- Price
- AIRG $9.66
- RLMD $3.18
- Analyst Decision
- AIRG Strong Buy
- RLMD Hold
- Analyst Count
- AIRG 2
- RLMD 2
- Target Price
- AIRG $11.75
- RLMD $7.50
- AVG Volume (30 Days)
- AIRG 35.1K
- RLMD 111.9K
- Earning Date
- AIRG 11-12-2024
- RLMD 11-07-2024
- Dividend Yield
- AIRG N/A
- RLMD N/A
- EPS Growth
- AIRG N/A
- RLMD N/A
- EPS
- AIRG N/A
- RLMD N/A
- Revenue
- AIRG $55,586,000.00
- RLMD N/A
- Revenue This Year
- AIRG $13.95
- RLMD N/A
- Revenue Next Year
- AIRG $18.52
- RLMD N/A
- P/E Ratio
- AIRG N/A
- RLMD N/A
- Revenue Growth
- AIRG N/A
- RLMD N/A
- 52 Week Low
- AIRG $2.25
- RLMD $1.88
- 52 Week High
- AIRG $10.34
- RLMD $7.22
- Technical
- Relative Strength Index (RSI)
- AIRG 54.95
- RLMD 39.24
- Support Level
- AIRG $9.12
- RLMD $3.06
- Resistance Level
- AIRG $10.34
- RLMD $3.43
- Average True Range (ATR)
- AIRG 0.43
- RLMD 0.20
- MACD
- AIRG -0.02
- RLMD -0.04
- Stochastic Oscillator
- AIRG 49.33
- RLMD 16.30
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.